VCYT
Companies
NASDAQ
Veracyte Inc.
Health Care
$26.82
-$12.78 (-32.27%)
Price Chart
Overview
About VCYT
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.
Market Cap
$1.6B
Volume
27.2M
Avg. Volume
28.4M
P/E Ratio
72.2
Dividend Yield
0.00%
Employees
686.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.72
High Correlation
Volatility
High (0.56)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, VCYT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.6B
Volume27.2M
P/E Ratio72.20
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 25, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025